Social and clinical predictors of prostate cancer treatment decisions among men in South Carolina

Cancer Causes and Control

Volumn 22, Issue 11, 2011, Pages 1597-1606

  Wagner, Sara E ^a   Drake, Bettina F ^b,c   Elder, Keith ^d   Hébert, James R ^e,f  

^a UNIVERSITY OF GEORGIA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Washington University in St Louis School of Medicine   (United States)

^d SAINT LOUIS UNIVERSITY   (United States)

^e UNIVERSITY OF SOUTH CAROLINA   (United States)

^f South Carolina Statewide Cancer Prevention and Control Program   (United States)

Author keywords

Decision making; Minority health; Prostatic neoplasms

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; COHORT ANALYSIS; FAMILY; FRIEND; HUMAN; IMPOTENCE; INCONTINENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT DECISION MAKING; PHYSICIAN; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; RACE; SOCIAL ASPECT; UNITED STATES;

AFRICAN AMERICANS; AGED; COHORT STUDIES; DECISION MAKING; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUESTIONNAIRES; SOCIAL ENVIRONMENT; SOUTH CAROLINA;

EID: 82955247655     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-011-9836-2     Document Type: Article

References (41)

1. Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL (2008) Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 148(6):435-448 (Pubitemid 351665443)
2. Davison BJ, Degner LF, Morgan TR (1995) Information and decision-making preferences of men with prostate cancer. Oncol Nurs Forum 22(9):1401-1408
3. Maliski SL, Heilemann MV, McCorkle R (2002) From "death sentence" to "good cancer": couples' transformation of a prostate cancer diagnosis. Nurs Res 51(6):391-397
4. Srirangam SJ, Pearson E, Grose C, Brown SC, Collins GN, O'Reilly PH (2003) Partner's influence on patient preference for treatment in early prostate cancer. BJU Int 92(4):365-369 (Pubitemid 37100509)
5. O'Rourke ME (2001) Decision making and prostate cancer treatment selection: A review. Semin Oncol Nurs 17(2):108-117
6. Fischer M, Visser A, Voerman B, Garssen B, van Andel G, Bensing J (2006) Treatment decision making in prostate cancer: patients' participation in complex decisions. Patient Educ Couns 63(3):308-313 (Pubitemid 44511881)
7. Volk RJ, Cantor SB, Cass AR, Spann SJ, Weller SC, Krahn MD (2004) Preferences of husbands and wives for outcomes of prostate cancer screening and treatment. J Gen Intern Med 19(4):339-348 (Pubitemid 38530505)
8. Feldman-Stewart D, Brundage MD, Van Manen L, Svenson O (2004) Patient-focused decision-making in early-stage prostate cancer: insights from a cognitively based decision aid. Health Expect 7(2):126-141 (Pubitemid 38661167)
9. Diefenbach MA, Dorsey J, Uzzo RG, Hanks GE, Greenberg RE, Horwitz E et al (2002) Decision-making strategies for patients with localized prostate cancer. Semin Urol Oncol 20(1):55-62 (Pubitemid 34132326)
10. Gwede CK, Pow-Sang J, Seigne J, Heysek R, HelalM, Shade K et al (2005) Treatment decision-making strategies and influences in patientswith localized prostate carcinoma. Cancer 104(7):1381-1390 (Pubitemid 41356153)
11. Holmboe ES, Concato J (2000) Treatment decisions for localized prostate cancer: Asking men what's important. J Gen Intern Med 15(10):694-701
12. Hall JD, Boyd JC, LippertMC, Theodorescu D (2003)Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey. Urology 61(2):402-407 (Pubitemid 36206541)
13. Mazur DJ, Hickam DH (1996) Patient preferences for management of localized prostate cancer. West J Med 165(1-2):26-30 (Pubitemid 26314037)
14. Steginga SK, Occhipinti S, Gardiner RA, Yaxley J, Heathcote P (2002) Making decisions about treatment for localized prostate cancer. BJU Int 89(3):255-260 (Pubitemid 34158457)
15. Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF et al (2004) Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst 96(18):1358-1367 (Pubitemid 39406169)
16. Chapple A, Ziebland S, Herxheimer A, McPherson A, Shepperd S, Miller R (2002) Is 'watchful waiting' a real choice for men with prostate cancer? A qualitative study. BJU Int 90(3):257-264 (Pubitemid 34989073)
17. Berry DL, Ellis WJ, Woods NF, Schwien C, Mullen KH, Yang C (2003) Treatment decision-making by men with localized prostate cancer: the influence of personal factors. Urol Oncol 21(2):93-100 (Pubitemid 41123432)
18. Berry DL, Ellis WJ, Russell KJ, Blasko JC, Bush N, Blumenstein B et al (2006) Factors that predict treatment choice and satisfaction with the decision in men with localized prostate cancer. Clin Genitourin Cancer 5(3):219-226 (Pubitemid 46190384)
19. Hoffman RM, Harlan LC, Klabunde CN, Gilliland FD, Stephenson RA, Hunt WC et al (2003) Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study. J Gen Intern Med 1810: 845-853 (Pubitemid 37281780)
20. Ramsey SD, Zeliadt SB, Arora NK, Potosky AL, Blough DK, Hamilton AS et al (2009) Access to information sources and treatment considerations among men with local stage prostate cancer. Urology 74(3):509-515
21. Denberg TD, Beaty BL, Kim FJ, Steiner JF (2005) Marriage and ethnicity predict treatment in localized prostate carcinoma. Cancer 103(9):1819-1825 (Pubitemid 40563253)
22. Shankar S, Selvin E, Alberg AJ (2002) Perceptions of cancer in an African-American community: A focus group report. Ethn Dis 12(2):276-283 (Pubitemid 34520555)
23. Pisu M, Oliver JS, Kim YI, Elder K, Martin M, Richardson LC (2010) Treatment for older prostate cancer patients: disparities in a southern state. Med Care 48(10):915-922
24. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W et al (2010) SEER cancer statistics review, 1975-2007, National Cancer Institute. Bethesda, MD, http://seer. cancer.gov/csr/1975-2007/, based on November 2009 SEER data submission, posted to the SEER web site
25. Drake BF, Keane TE, Mosley CM, Adams SA, Elder KT, Modayil MVet al (2006) Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology. J S C Med Assoc 102:241-249
26. Greene FL, Page DL, Fleming ID (2002) American Join Committee on Cancer, 6th edn. Springer, New York
27. Zeliadt SB, Ramsey SD, Penson DF, Hall IJ, Ekwueme DU, Stroud L et al (2006) Why do men choose one treatment over another? A review of patient decision making for localized prostate cancer. Cancer 106:1865-1874 (Pubitemid 43673200)
28. Zeliadt SB, Moinpour CM, Blough DK, Penson DF, Hall IJ, Smith JL et al (2010) Preliminary treatment considerations among men with newly diagnosed prostate cancer. Am J Manag Care 16(5):e121-e130
29. O'Rourke ME (2007) Choose wisely: therapeutic decisions and quality of life in patients with prostate cancer. Clin J Oncol Nurs 11(3):401-408
30. Davidson JB, Oliffe JL, Pickles T, Mroz L (2009) Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer. Oncol Nurs Forum 36(1):8
31. Cox J, Amling CL (2008) Current decision-making in prostate cancer therapy. Curr Opin Urol 18(3):275-278 (Pubitemid 351489378)
32. Christie KM, Meyerowitz BE, Giedzinska-Simons A, Gross M, Agus DB (2009) Predictors of affect following treatment decision-making for prostate cancer: conversations, cognitive processing, and coping. Psychooncology 18(5):508-514
33. Talcott JA, Spain P, Clark JA, Carpenter WR, Do YK, Hamilton RJ et al (2007) Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experience. Cancer 15:1599-1606 (Pubitemid 46595696)
34. Elder K, Drake BF, Wagner S, Hebert J (2008) An examination of the social and clinical influences in prostate cancer treatment in African American and White men. J Health Dispar Res Pract 2(2):125-131
35. Lin GA, Aaronson DS, Knight SJ, Carroll PR, Dudley RA (2009) Patient decision aids for prostate cancer treatment: A systematic review of the literature. CA Cancer J Clin 59:379-390
36. Kilbridge KL, Fraser G, Krahn M, Nelson EM, Conaway M, Bashore R et al (2009) Lack of comprehension of common prostate cancer terms in an underserved population. J Clin Oncol 27(12):2015-2021
37. Klein JB, Nguyen CT, Saffore L, Modlin C III, Modlin CS Jr (2010) Racial disparities in urologic health care. J Natl Med Assoc 102(2):108-117
38. Maliski SL, Rivera S, Connor S, Lopez G, Litwin MS (2008) Renegotiating masculine identity after prostate cancer treatment. Qual Health Res 18(12):1609-1620
39. Ukoli FA, Lynch BS, Adams-Campbell LL (2006) Radical prostatectomy and quality of life among African Americans. Ethn Dis 16(4):988-993
40. Moses KA, Paciorek AT, Penson DF, Carroll PR, Master VA (2010) Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. J Clin Oncol 28(6):1069-1074
41. Richert-Boe KE, Weinmann S, Shapiro JA, Rybicki BA, Enger SM, Van Den Eeden SK et al (2008) Racial differences in treatment of early-stage prostate cancer. Urology 71(6):1172-1176